Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)
-
* Corresponding author: Dirk Vordermark vordermark_d@klinik.uni-wuerzburg.de
BMC Cancer 2006, 6:247 doi:10.1186/1471-2407-6-247
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 16 Mar 2006 | |
| Reviewer's Report | Henry Friedman | 07 Apr 2006 | |
| Reviewer's Report | Jerome Posner | 16 Apr 2006 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 28 Sep 2006 |
| Resubmission - Version 4 | Manuscript | Author's comment | 16 Oct 2006 |
| Editorial acceptance | 17 Oct 2006 | ||
| Published | 18 Oct 2006 |